Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

被引：0
|
作者：
Virk, Zain [1 ]
Leaf, Rebecca Karp [2 ]
Kuter, David J. [3 ,4 ]
Goodarzi, Katayoon [2 ]
Connell, Nathan T. [4 ,5 ]
Connors, Jean M. [6 ]
Al-Samkari, Hanny [4 ,7 ]
机构：
[1] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Hematol, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA USA
[7] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179601
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Avatrombopag for adults with early versus chronic immune thrombocytopenia
    Virk, Zain M.
    Leaf, Rebecca K.
    Kuter, David J.
    Goodarzi, Katayoon
    Connell, Nathan T.
    Connors, Jean M.
    Al-Samkari, Hanny
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : 155 - 162
  • [2] Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
    Cheloff, Abraham Z.
    Al-Samkari, Hanny
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 313 - 321
  • [3] An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia
    Song, Andrew B.
    Al-Samkari, Hanny
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (08) : 783 - 791
  • [4] Avatrombopag for the Treatment of Immune Thrombocytopenia
    Labanca, Caterina
    Vigna, Ernesto
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Mendicino, Francesco
    Carida, Giulio
    Lucia, Eugenio
    Olivito, Virginia
    Puccio, Noemi
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [5] Avatrombopag for the treatment of immune thrombocytopenia
    Dlugosz-Danecka, Monika
    Zdziarska, Joanna
    Jurczak, Wojciech
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (04) : 327 - 339
  • [6] Avatrombopag for the Treatment of Immune Thrombocytopenia and Periprocedural Thrombocytopenia Associated With Chronic Liver Disease
    Tran, Thuy B.
    Downing, Lauren
    Elmes, Joseph B.
    Arnall, Justin R.
    Moore, Donald C.
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (01) : 184 - 189
  • [7] Efficacy and Safety of Avatrombopag in Japanese Adults with Chronic Immune Thrombocytopenia: Open-Label, Phase 3 Study
    Yamaguchi, Hiroki
    Iino, Masaki
    Imamura, Yutaka
    Kowata, Shugo
    Yamamoto, Ryusuke
    Yamanouchi, Jun
    Fujii, Masato
    Zhang, Jessica
    Tomiyama, Yoshiaki
    Jamieson, Brian
    BLOOD, 2024, 144 : 5426 - 5427
  • [8] Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
    Mei, Heng
    Zhou, Hu
    Hou, Ming
    Sun, Jing
    Zhang, Lei
    Luo, Jianmin
    Jiang, Zhongxing
    Ye, Xu
    Xu, Yajing
    Lu, Jun
    Wang, Hui
    Hui, Aimin
    Zhou, Yongchun
    Hu, Yu
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [9] Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia
    Jain, Shivi
    Gernsheimer, Terry
    Kolodny, Scott
    Bernheisel, Chelsea
    Vredenburg, Michael
    Panch, Sandhya R.
    PLATELETS, 2023, 34 (01)
  • [10] Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
    Abdelsamia, Mahmoud
    Farid, Saira
    Dean, Steven
    Cataland, Spero R.
    HEMATOLOGY REPORTS, 2023, 15 (03) : 518 - 523
12345